Published in Neuron on April 11, 2013
Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors. Cell (2014) 3.19
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. Cell (2015) 1.49
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. Nat Rev Neurosci (2014) 1.18
Revitalizing psychiatric therapeutics. Neuropsychopharmacology (2014) 1.05
Synaptic proteins and receptors defects in autism spectrum disorders. Front Cell Neurosci (2014) 0.98
GABAergic signaling as therapeutic target for autism spectrum disorders. Front Pediatr (2014) 0.97
A novel computational biostatistics approach implies impaired dephosphorylation of growth factor receptors as associated with severity of autism. Transl Psychiatry (2014) 0.96
Epigenetic findings in autism: new perspectives for therapy. Int J Environ Res Public Health (2013) 0.95
Neuroligins Sculpt Cerebellar Purkinje-Cell Circuits by Differential Control of Distinct Classes of Synapses. Neuron (2015) 0.93
De novo TBR1 mutations in sporadic autism disrupt protein functions. Nat Commun (2014) 0.92
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release. J Neurosci (2015) 0.91
Conditional neuroligin-2 knockout in adult medial prefrontal cortex links chronic changes in synaptic inhibition to cognitive impairments. Mol Psychiatry (2015) 0.91
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice. J Dev Behav Pediatr (2015) 0.90
Altered network topologies and hub organization in adults with autism: a resting-state fMRI study. PLoS One (2014) 0.89
Distinct circuit-dependent functions of presynaptic neurexin-3 at GABAergic and glutamatergic synapses. Nat Neurosci (2015) 0.88
Shank3-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit. Front Cell Neurosci (2015) 0.88
Autism-associated mutation inhibits protein kinase C-mediated neuroligin-4X enhancement of excitatory synapses. Proc Natl Acad Sci U S A (2015) 0.87
Glial control of endocannabinoid heterosynaptic modulation in hypothalamic magnocellular neuroendocrine cells. J Neurosci (2013) 0.87
Neurobiology of autism gene products: towards pathogenesis and drug targets. Psychopharmacology (Berl) (2014) 0.86
Perinatal exposure to bisphenol-A impairs spatial memory through upregulation of neurexin1 and neuroligin3 expression in male mouse brain. PLoS One (2014) 0.85
Reduced inhibitory gate in the barrel cortex of Neuroligin3R451C knock-in mice, an animal model of autism spectrum disorders. Physiol Rep (2014) 0.84
Novel 3D microscopic analysis of human placental villous trees reveals unexpected significance of branching angles. Sci Rep (2014) 0.83
Identifying novel interventional strategies for psychiatric disorders: integrating genomics, 'enviromics' and gene-environment interactions in valid preclinical models. Br J Pharmacol (2014) 0.82
Imbalance of excitatory/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1(+/-) patients and in foxg1(+/-) mice. Eur J Hum Genet (2015) 0.82
On the Teneurin track: a new synaptic organization molecule emerges. Front Cell Neurosci (2015) 0.81
Neuroligins provide molecular links between syndromic and nonsyndromic autism. Sci Signal (2013) 0.80
Selective Dysregulation of Hippocampal Inhibition in the Mouse Lacking Autism Candidate Gene CNTNAP2. J Neurosci (2015) 0.79
Evidence for a common endocannabinoid-related pathomechanism in autism spectrum disorders. Neuron (2013) 0.79
Neuregulin-1 impairs the long-term depression of hippocampal inhibitory synapses by facilitating the degradation of endocannabinoid 2-AG. J Neurosci (2013) 0.79
Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links. Neuroscience (2015) 0.78
Endogenous cannabinoid signaling at inhibitory interneurons. Curr Opin Neurobiol (2013) 0.78
The interplay between synaptic activity and neuroligin function in the CNS. Biomed Res Int (2015) 0.78
Synapses as therapeutic targets for autism spectrum disorders: an international symposium held in pavia on july 4th, 2014. Front Cell Neurosci (2014) 0.77
A neuroligin-3 mutation implicated in autism causes abnormal aggression and increases repetitive behavior in mice. Mol Autism (2015) 0.77
Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition. Transl Psychiatry (2015) 0.76
Single-cell RNAseq reveals cell adhesion molecule profiles in electrophysiologically defined neurons. Proc Natl Acad Sci U S A (2016) 0.76
The utility of rodent models of autism spectrum disorders. Curr Opin Neurol (2015) 0.76
Endocannabinoid Signaling in Autism. Neurotherapeutics (2015) 0.76
Mouse Genetic Models of Human Brain Disorders. Front Genet (2016) 0.76
The role of oxidative stress, inflammation and acetaminophen exposure from birth to early childhood in the induction of autism. J Int Med Res (2017) 0.75
Advancing multiscale structural mapping of the brain through fluorescence imaging and analysis across length scales. Interface Focus (2016) 0.75
Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling. PLoS One (2015) 0.75
Modulation of excitation on parvalbumin interneurons by neuroligin-3 regulates the hippocampal network. Nat Neurosci (2017) 0.75
Electrophysiological Measurement of Cannabinoid-Mediated Synaptic Modulation in Acute Mouse Brain Slices. Curr Protoc Neurosci (2016) 0.75
Endocannabinoid signaling in social functioning: an RDoC perspective. Transl Psychiatry (2016) 0.75
Slitrk Missense Mutations Associated with Neuropsychiatric Disorders Distinctively Impair Slitrk Trafficking and Synapse Formation. Front Mol Neurosci (2016) 0.75
Social Isolation Alters Social and Mating Behavior in the R451C Neuroligin Mouse Model of Autism. Neural Plast (2017) 0.75
Endocannabinoid Mediates Excitatory Synaptic Function of β-Neurexins. Commentary: β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. Front Neurosci (2016) 0.75
Neuroligins Are Selectively Essential for NMDAR Signaling in Cerebellar Stellate Interneurons. J Neurosci (2016) 0.75
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder. Autism Open Access (2016) 0.75
Abnormal wiring of CCK(+) basket cells disrupts spatial information coding. Nat Neurosci (2017) 0.75
Autism Spectrum Disorders and Drug Addiction: Common Pathways, Common Molecules, Distinct Disorders? Front Neurosci (2016) 0.75
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms. Orphanet J Rare Dis (2015) 0.75
Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date. CNS Drugs (2015) 0.75
Cytokine-dependent bidirectional connection between impaired social behavior and susceptibility to seizures associated with maternal immune activation in mice. Epilepsy Behav (2015) 0.75
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus. Elife (2016) 0.75
Persistent inhibitory circuit defects and disrupted social behaviour following in utero exogenous cannabinoid exposure. Mol Psychiatry (2016) 0.75
Abnormal Astrocytosis in the Basal Ganglia Pathway of Git1(-/-) Mice. Mol Cells (2015) 0.75
Distinct roles for extracellular and intracellular domains in neuroligin function at inhibitory synapses. Elife (2016) 0.75
Developmental plasticity shapes synaptic phenotypes of autism-associated neuroligin-3 mutations in the calyx of Held. Mol Psychiatry (2016) 0.75
Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations. Int J Mol Sci (2017) 0.75
Loss of Neuroligin3 specifically downregulates retinal GABAAα2 receptors without abolishing direction selectivity. PLoS One (2017) 0.75
The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models. Int J Mol Sci (2017) 0.75
Conserved and divergent processing of neuroligin and neurexin genes: from the nematode C. elegans to human. Invert Neurosci (2014) 0.75
Unique vs. Redundant Functions of Neuroligin Genes in Shaping Excitatory and Inhibitory Synapse Properties. J Neurosci (2017) 0.75
Pharmacological Modulation of GABA Function in Autism Spectrum Disorders: A Systematic Review of Human Studies. J Autism Dev Disord (2016) 0.75
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron (2011) 10.61
Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science (2008) 9.24
Neuroligins and neurexins link synaptic function to cognitive disease. Nature (2008) 9.23
Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci (2007) 8.76
The molecular logic of endocannabinoid signalling. Nat Rev Neurosci (2003) 7.78
A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science (2007) 6.64
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature (2001) 6.12
Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell (2004) 6.08
Neuroligin 1: a splice site-specific ligand for beta-neurexins. Cell (1995) 5.97
Neuroligins determine synapse maturation and function. Neuron (2006) 5.70
Role of endogenous cannabinoids in synaptic signaling. Physiol Rev (2003) 5.70
Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc Natl Acad Sci U S A (1999) 5.39
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12
Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron (2003) 4.32
Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron (2007) 4.32
Structures, alternative splicing, and neurexin binding of multiple neuroligins. J Biol Chem (1996) 4.31
Perisomatic inhibition. Neuron (2007) 3.79
Interneuron Diversity series: Rhythm and mood in perisomatic inhibition. Trends Neurosci (2003) 3.45
Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc Natl Acad Sci U S A (2009) 2.93
Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J Neurosci (2005) 2.64
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med (2008) 2.60
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol (2002) 2.59
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol (2003) 2.45
Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin. Neuron (2009) 2.44
LRRTM2 functions as a neurexin ligand in promoting excitatory synapse formation. Neuron (2009) 2.30
Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res (2008) 2.08
Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses. Eur J Neurosci (2007) 1.83
Supply and demand for endocannabinoids. Trends Neurosci (2011) 1.78
Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1. Eur J Neurosci (2010) 1.77
Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons. J Neurosci (2009) 1.74
Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J Physiol (2006) 1.71
Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc Natl Acad Sci U S A (2004) 1.64
Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science (2012) 1.63
Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci (2012) 1.60
Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism. Neuron (1994) 1.59
A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export. J Neurosci (2009) 1.59
Estimation of nonuniform quantal parameters with multiple-probability fluctuation analysis: theory, application and limitations. J Neurosci Methods (2003) 1.49
Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci (2010) 1.48
Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. J Neurosci (2005) 1.46
An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus. EMBO J (2011) 1.45
Long-term plasticity at inhibitory synapses. Curr Opin Neurobiol (2011) 1.41
Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci (2006) 1.40
Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. Proc Natl Acad Sci U S A (2011) 1.37
Release probability-dependent scaling of the postsynaptic responses at single hippocampal GABAergic synapses. J Neurosci (2006) 1.27
Complementary modulation of somatic inhibition by opioids and cannabinoids. J Neurosci (2008) 1.23
Regulation of fast-spiking basket cell synapses by the chloride channel ClC-2. Nat Neurosci (2010) 1.18
Distinct synaptic properties of perisomatic inhibitory cell types and their different modulation by cholinergic receptor activation in the CA3 region of the mouse hippocampus. Eur J Neurosci (2010) 1.09
RIM genes differentially contribute to organizing presynaptic release sites. Proc Natl Acad Sci U S A (2012) 1.07
Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J Neurosci (2010) 1.03
Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know. J Physiol (2012) 1.00
Folding anomalies of neuroligin3 caused by a mutation in the alpha/beta-hydrolase fold domain. Chem Biol Interact (2010) 0.89
Direct conversion of fibroblasts to functional neurons by defined factors. Nature (2010) 18.76
AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci (2002) 13.09
Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci (2006) 12.37
Membrane fusion. Cell (2003) 7.68
Induction of human neuronal cells by defined transcription factors. Nature (2011) 6.84
Synaptic scaling mediated by glial TNF-alpha. Nature (2006) 6.76
A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science (2007) 6.64
Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell (2005) 6.31
Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron (2003) 6.19
Synaptic plasticity and addiction. Nat Rev Neurosci (2007) 6.08
Neuroligins determine synapse maturation and function. Neuron (2006) 5.70
SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science (2002) 5.69
Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science (2010) 5.42
Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature (2003) 5.19
Input-specific control of reward and aversion in the ventral tegmental area. Nature (2012) 4.60
Control of synaptic strength by glial TNFalpha. Science (2002) 4.46
RIM1alpha forms a protein scaffold for regulating neurotransmitter release at the active zone. Nature (2002) 4.37
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature (2007) 4.36
A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis. Cell (2006) 4.36
Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron (2007) 4.32
Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron (2011) 3.93
A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins. Neuron (2005) 3.93
A dual-Ca2+-sensor model for neurotransmitter release in a central synapse. Nature (2007) 3.91
Striatal plasticity and basal ganglia circuit function. Neuron (2008) 3.89
Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron (2011) 3.89
Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci (2007) 3.74
Three-dimensional structure of the complexin/SNARE complex. Neuron (2002) 3.69
Activity-dependent regulation of dendritic synthesis and trafficking of AMPA receptors. Nat Neurosci (2004) 3.64
Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc Natl Acad Sci U S A (2012) 3.52
Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci (2005) 3.38
Snares and Munc18 in synaptic vesicle fusion. Nat Rev Neurosci (2002) 3.33
Complexin controls the force transfer from SNARE complexes to membranes in fusion. Science (2009) 3.30
RIM1alpha is required for presynaptic long-term potentiation. Nature (2002) 3.28
Synaptotagmin-1, -2, and -9: Ca(2+) sensors for fast release that specify distinct presynaptic properties in subsets of neurons. Neuron (2007) 3.18
Close membrane-membrane proximity induced by Ca(2+)-dependent multivalent binding of synaptotagmin-1 to phospholipids. Nat Struct Mol Biol (2006) 3.14
CASK Functions as a Mg2+-independent neurexin kinase. Cell (2008) 3.10
Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology (2007) 3.10
Excitation-neurogenesis coupling in adult neural stem/progenitor cells. Neuron (2004) 3.09
Autonomous function of synaptotagmin 1 in triggering synchronous release independent of asynchronous release. Neuron (2005) 3.09
Tumor necrosis factor-alpha mediates one component of competitive, experience-dependent plasticity in developing visual cortex. Neuron (2008) 3.07
Dissection of synapse induction by neuroligins: effect of a neuroligin mutation associated with autism. J Biol Chem (2005) 3.06
Munc18-1 binds directly to the neuronal SNARE complex. Proc Natl Acad Sci U S A (2007) 3.03
The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci (2010) 3.02
CREB modulates excitability of nucleus accumbens neurons. Nat Neurosci (2006) 2.95
Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc Natl Acad Sci U S A (2009) 2.93
RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction. Cell (2011) 2.90
Monitoring synaptic transmission in primary neuronal cultures using local extracellular stimulation. J Neurosci Methods (2006) 2.80
A broken alpha -helix in folded alpha -Synuclein. J Biol Chem (2003) 2.80
Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci (2004) 2.73
Beta-catenin is critical for dendritic morphogenesis. Nat Neurosci (2003) 2.70
Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc Natl Acad Sci U S A (2004) 2.62
Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens. Nature (2012) 2.61
Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord (2009) 2.61
A developmental switch in the signaling cascades for LTP induction. Nat Neurosci (2003) 2.61
Integrative genomic and functional analyses reveal neuronal subtype differentiation bias in human embryonic stem cell lines. Proc Natl Acad Sci U S A (2007) 2.60
Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci (2004) 2.59
Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. Genomics (2002) 2.58
Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior. J Neurosci (2010) 2.57
Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature (2013) 2.55
Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature (2013) 2.55
Activity-dependent IGF-1 exocytosis is controlled by the Ca(2+)-sensor synaptotagmin-10. Cell (2011) 2.52
Complexin clamps asynchronous release by blocking a secondary Ca(2+) sensor via its accessory α helix. Neuron (2010) 2.52
Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron (2013) 2.51
Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. Cell Stem Cell (2011) 2.49
Conformational switch of syntaxin-1 controls synaptic vesicle fusion. Science (2008) 2.44
Structures of neuroligin-1 and the neuroligin-1/neurexin-1 beta complex reveal specific protein-protein and protein-Ca2+ interactions. Neuron (2007) 2.43
Sly1 binds to Golgi and ER syntaxins via a conserved N-terminal peptide motif. Dev Cell (2002) 2.43
The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. Neuron (2004) 2.43
Synaptotagmin-2 is essential for survival and contributes to Ca2+ triggering of neurotransmitter release in central and neuromuscular synapses. J Neurosci (2006) 2.42
Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nat Neurosci (2010) 2.40
Presenilins are essential for regulating neurotransmitter release. Nature (2009) 2.39
Distinct neuronal coding schemes in memory revealed by selective erasure of fast synchronous synaptic transmission. Neuron (2012) 2.35
Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J Biol Chem (2004) 2.31
How Tlg2p/syntaxin 16 'snares' Vps45. EMBO J (2002) 2.31
Beta phorbol ester- and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs. Cell (2002) 2.31
LRRTM2 functions as a neurexin ligand in promoting excitatory synapse formation. Neuron (2009) 2.30
RIM determines Ca²+ channel density and vesicle docking at the presynaptic active zone. Neuron (2011) 2.29
Alternative N-terminal domains of PSD-95 and SAP97 govern activity-dependent regulation of synaptic AMPA receptor function. Neuron (2006) 2.25
A complete genetic analysis of neuronal Rab3 function. J Neurosci (2004) 2.21
The membrane fusion enigma: SNAREs, Sec1/Munc18 proteins, and their accomplices--guilty as charged? Annu Rev Cell Dev Biol (2012) 2.19
Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J Neurosci (2005) 2.18
Cell biology of Ca2+-triggered exocytosis. Curr Opin Cell Biol (2010) 2.15
Molecular dissociation of the role of PSD-95 in regulating synaptic strength and LTD. Neuron (2008) 2.15
Destabilization of the postsynaptic density by PSD-95 serine 73 phosphorylation inhibits spine growth and synaptic plasticity. Neuron (2008) 2.15
Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J Neurosci (2008) 2.15
The presynaptic active zone protein RIM1alpha is critical for normal learning and memory. Neuron (2004) 2.14
Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci U S A (2005) 2.13
Synaptobrevin is essential for fast synaptic-vesicle endocytosis. Nat Cell Biol (2004) 2.11
Activation of NR2B-containing NMDA receptors is not required for NMDA receptor-dependent long-term depression. Neuropharmacology (2006) 2.10
Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A (2007) 2.03
Dual modes of Munc18-1/SNARE interactions are coupled by functionally critical binding to syntaxin-1 N terminus. J Neurosci (2007) 2.02
A conformational switch in the Piccolo C2A domain regulated by alternative splicing. Nat Struct Mol Biol (2003) 1.98
Selective capability of SynCAM and neuroligin for functional synapse assembly. J Neurosci (2005) 1.97
A neural circuit for memory specificity and generalization. Science (2013) 1.96
Synaptotagmin-1 functions as a Ca2+ sensor for spontaneous release. Nat Neurosci (2009) 1.95
CSPα promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity. Nat Cell Biol (2010) 1.95